maintelyte sol.inf 50mg/ml
baxter hellas ΕΠΕ Μαρίνου Αντύπα 47 & Ανάφης, 141 21 Ν. Ηράκλειο 210.2880000 - dextrose(glucose) monohydrate; sodium chloride; potassium chloride; sodium acetate trihydrate; magnesium chloride hexahydrate - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - 50mg/ml - dextrose(glucose) monohydrate 55g; sodium chloride 1g; potassium chloride 1,5g; sodium acetate trihydrate 3,13g; magnesium chloride hexahydrate 0,3g - electrolytes with carbohydrates
maintelyte 50mg/ml solution for infusion
baxter (hellas) epe (0000008332) 47, marinou antypa & anafis str, n. herakleio-attiki, 141 21 - glucose monohydrate; sodium chloride; potassium chloride; sodium acetate trihydrate; magnesium chloride hexahydrate - solution for infusion - 50mg/ml - glucose monohydrate (0005996101) 55g; sodium chloride (0007647145) 1g; potassium chloride (0007447407) 1,5g; sodium acetate trihydrate (0006131904) 3,13g; magnesium chloride hexahydrate (0007791186) 0,3g
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.
tekturna
novartis europharm ltd. - αλισκιρένη - Υπέρταση - Παράγοντες που δρουν στο σύστημα ρενίνης-αγγειοτενσίνης - Θεραπεία της ιδιοπαθούς υπέρτασης.
fluvastatin xl/pharmathen international pr.tab 80mg/tab
pharmathen international s.a., greece Δερβενακίων 4,, 153 51 153 51, Παλλήνη Αττικής 210.66 66 636 - fluvastatin sodium - pr.tab (ΔΙΣΚΙΟ ΠΑΡΑΤΕΤΑΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ) - 80mg/tab - fluvastatin sodium 84,2mg - fluvastatin
valaciclovir/pharmathen international f.c.tab 500mg/tab
pharmathen international s.a., greece Δερβενακίων 4,, 153 51 153 51, Παλλήνη Αττικής 210.66 66 636 - valaciclovir hydrochloride - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 500mg/tab - valaciclovir hydrochloride 614,6mg - valaciclovir
fusidic acid/betamethasone valerate pharmascience international (20mg/1mg)/g cream
pharmascience international ltd (0000011496) lampousas 1, nicosia, 1095 - fusidic acid; betamethasone valerate - cream - (20mg/1mg)/g - fusidic acid (8000002385) 20mg; betamethasone valerate (0002152445) 1mg - betamethasone and antibiotics
lacosamide pharmascience international ltd 50mg film coated tablets
pharmascience international ltd (0000007813) julia house, themistokli dervi 3, nicosia, 1066 - lacosamide - film coated tablets - 50mg - lacosamide (8000003467) 50mg
lacosamide pharmascience international ltd 200mg film coated tablets
pharmascience international ltd (0000007813) julia house, themistokli dervi 3, nicosia, 1066 - lacosamide - film coated tablets - 200mg - lacosamide (8000003467) 200mg
lacosamide pharmascience international ltd 100mg film coated tablets
pharmascience international ltd (0000007813) julia house, themistokli dervi 3, nicosia, 1066 - lacosamide - film coated tablets - 100mg - lacosamide (8000003467) 100mg